Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Despite acknowledging that the "highly effective" injections had "transformed the treatment of obesity," the BMJ Group's release noted that "it is estimated that around half of people with obesity discontinue GLP-1 drugs within 12 months, so its important to understand what happens to body weight and risk markers for conditions like diabetes and heart disease after stopping treatment." The release stated, "To do this, a team of researchers from the University of Oxford searched registries and databases for trials and observational studies that compared the effects of any medication licensed for weight loss in adults with any non-drug weight loss intervention (behavioural weight management programmes) or placebo." Researchers looked at 37 studies published up to February 2025 involving 9,341 participants, per the data, which pointed out that the average duration of weight loss treatment was 39 weeks, with an average follow-up of 32 weeks
Mentioned in this episode www.fmpha.org IG: @fmpha FB: @fmpha.org Twitter: @fmphaorg LinkedIn: www.linkedin.com/company/fmpha www.drlaurencastle.com [] EPISODE 72: I FINISHED THE NAPODPOMO CHALLENGE
4 , e001504 (2015)
Consult a qualified healthcare professional before starting any prescription treatment
US$ 29.88
US$ 29.57
US$ 24.49
US$ 27.60
